12412
J. Am. Chem. Soc. 1997, 119, 12412-12413
Scheme 1
Synthesis of 7-Deoxyxestobergsterol A, a Novel
Pentacyclic Steroid of the Xestobergsterol Class1
Michael E. Jung*,2 and Ted W. Johnson
Department of Chemistry and Biochemistry
UniVersity of California at Los Angeles
Los Angeles, California 90095-1569
ReceiVed September 22, 1997
In 1992, Umeyama and co-workers reported the isolation of
xestobergsterols A and B, 1ab, novel pentacyclic steroids with
a cis C/D ring junction which are powerful inhibitors of
histamine release.3 Three years later, another member of this
novel class, xestobergsterol C, 1c, was isolated and the original
stereochemistry proposed for C23 was corrected.4 Another
inhibitor of histamine release is contignasterol, 2, which has a
similar structure but is missing the additional E ring.5 To date,
class, the nonnatural analogue 7-deoxyxestobergsterol A (1d)
by a route which should be applicable to the natural products.
Breslow has reported a very useful technique for “remote
functionalization” of steroids that involves the abstraction of a
tertiary hydrogen atom by a radical species generated by
photolysis of an appropriate precursor which is attached to the
steroid backbone so that it sits preferentially under one of the
several abstractable tertiary hydrogens in a steroid.10 We first
tested this process for the synthesis of the steroid skeleton
necessary for the xestobergsterols (Scheme 1). The diol 3,
prepared in 78% yield by hydroboration-oxidation of choles-
teryl acetate, was treated with the known acid 411 and excess
DEAD and triphenylphosphine to produce the monoester 5 in
60% yield. This selective Mitsunobu reaction proceeds well
due to the severe steric hindrance in the inversion of the 6R-
alcohol. Photolysis and cleavage with hydroxide followed by
protection gave the desired ∆14-alkene diacetate 6 in 45%
isolated yield along with 35% of the saturated 3R,6R-diacetate,
which could be recycled. Conversion of the alkene to the
desired 14â-H 15-ketone 7 was quite difficult. Simple hy-
droboration-oxidation gave mainly the 14R-H 15R-alcohol12
which could be oxidized to the 14R-H 15-ketone, but this
compound was not epimerized to the desired epimer. Therefore
a stereoselective route was developed. Epoxidation13 of 6 gave
the R-epoxide which was opened with hydrogen over platinum
oxide in acetic acid to give the 14â-H 15R-alcohol which was
then oxidized with PCC to the desired ketone 7. Treatment of
7 with either strong base or strong acid caused epimerization
to the more stable 14R-H 15-ketone.
very little has been published on routes to these molecules.6
All of these compounds strongly inhibited histamine release
from rat mast cells induced by anti-IgE in a dose-dependent
manner (1a IC50 0.05 µM; 1b 0.10 µM; and 2 0.8 µM).3,7 Since
the well-known antiallergy drug disodium cromoglycate has an
IC50 of 262 µM, these compounds are much more potent
inhibitors of histamine release, being up to 5000 times more
active inhibitors. Contignasterol is also very potent in both in
vivo and in vitro models of allergen-induced bronchoconstriction
and airway smooth muscle contraction and therefore is extremely
effective as an antiasthma agent.8 Recently it has been shown
that the mechanism of action of xestobergsterol A is through
strong inhibition of phosphatidylinositol phospholipase C (PI-
PLC).9 We report herein the first total synthesis of this structural
(1) Presented at the 213th National American Chemical Society meeting,
San Francisco, CA, April 1997, ORGN 118.
(2) American Chemical Society Arthur C. Cope Scholar, 1995.
(3) Shoji, N.; Umeyama, A.; Shin, K.; Takeda, K.; Arihara, S.; Kobayashi,
J.; Takei, M. J. Org. Chem. 1992, 57, 2996.
(4) Kobayashi, J.; Shinonaga, H.; Shigemori, H.; Umeyama, A.; Shoji,
N.; Arihara, S. J. Nat. Prod. 1995, 58, 312.
(5) Burgoyne, D. L.; Andersen, R. J.; Allen, T. M. J. Org. Chem. 1992,
57, 525.
(6) Krafft, M. E.; Chirico, X. Tetrahedron Lett. 1994, 35, 4511.
(7) Bramley, A. M.; Langlands, J. M.; Jones, A. K.; Burgoyne, D. L.;
Li, Y.; Andersen, R. J.; Salari, H. Br. J. Pharmacol. 1995, 115, 1433.
(8) Takei, M.; Burgoyne, D. L.; Andersen, R. J. J. Pharm. Sci. 1994,
83, 1234.
(9) Takei, M.; Umeyama, A.; Shoji, N.; Arihara, S.; Endo, K. Experientia
1993, 49, 145.
To determine the strategy necessary for final production of
the cis C/D ring junction as well as the final E ring, we carried
out a series of molecular mechanics calculations on a tricyclic
(10) (a) Breslow, R. Chemtracts 1988, 1, 333. (b) Breslow, R.; Baldwin,
S.; Flechtner, T.; Kalicky, P.; Liu, S.; Washburn, W. J. Am. Chem. Soc.
1973, 95, 3251.
(11) Zderic, J. A.; Kubitschek, M. J.; Bonner, W. A. J. Org. Chem. 1961,
26, 1635.
(12) In addition to the major product, a small amount of the desired 14â-H
15â-alcohol was also isolated (an approximate 10:1 ratio), which could be
taken on to 7 by simple oxidation.
(13) Lardon, A.; Sigg, H. P.; Reichstein, T. HelV. Chim. Acta 1959, 42,
1457.
S0002-7863(97)03318-0 CCC: $14.00 © 1997 American Chemical Society